🇺🇸 FDA
Patent

US 9662306

Compositions and methods for diagnosis and treatment of metabolic syndrome

granted A61KA61K31/20A61K31/201

Quick answer

US patent 9662306 (Compositions and methods for diagnosis and treatment of metabolic syndrome) held by United States of America as represented by the Secretary of the Air Force expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/20, A61K31/201, A61K31/202